Mirum Pharmaceuticals Inc...
(MIRM)
undefined
undefined%
At close: undefined
43.09
0.05%
After-hours Jan 06, 2025, 04:00 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| PE Ratio | -7.39 | -4.86 | -5.76 | -4.27 | -10.73 | -17.51 |
| PS Ratio | 6.48 | 8.56 | 25.27 | n/a | n/a | n/a |
| PB Ratio | 4.85 | -1.68 | 4.02 | -2.55 | -8.06 | -29.42 |
| P/FCF Ratio | -13.26 | -5.48 | -3.19 | -4.94 | -14.22 | -38.57 |
| P/OCF Ratio | -17.01 | -5.49 | -3.64 | -4.95 | -14.32 | -814.2 |
| OCF/S Ratio | -0.38 | -1.56 | -6.94 | n/a | n/a | n/a |
| Debt / Equity Ratio | 1.23 | -0.01 | 0.02 | -0.02 | -0.05 | n/a |
| Quick Ratio | 4.19 | 2.85 | 3.88 | 12.80 | 9.13 | 21.22 |
| Current Ratio | 4.45 | 2.94 | 3.91 | 12.80 | 9.13 | 21.22 |
| Asset Turnover | 0.29 | 0.22 | 0.06 | n/a | n/a | n/a |
| Interest Coverage | -7.23 | -8.21 | -9.86 | -311.33 | n/a | n/a |
| Return on Equity (ROE) | -0.66 | 0.35 | -0.7 | 0.60 | 0.75 | 1.68 |
| Return on Assets (ROA) | -0.25 | -0.38 | -0.29 | -0.43 | -0.36 | -0.33 |
| Return on Capital (ROIC) | -0.2 | -0.46 | -0.69 | -0.47 | -0.41 | -0.06 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 74.76% | 83.94% | 90.06% | n/a | n/a | n/a |
| Net Profit Margin | -87.68% | -176.05% | -438.85% | n/a | n/a | n/a |
| Pretax Profit Margin | -87.15% | -184.36% | -438.66% | n/a | n/a | n/a |
| Operating Profit Margin | -58.57% | -170.28% | -906.12% | n/a | n/a | n/a |
| FCF Margin | -48.85% | -156.26% | -793.09% | n/a | n/a | n/a |
| EBITDA Margin | -73.23% | -158.85% | -341.66% | n/a | n/a | n/a |